Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

103.66
+0.48000.47%
Post-market: 103.660.00000.00%16:15 EDT
Volume:81.65K
Turnover:8.46M
Market Cap:4.37B
PE:-100.81
High:103.96
Open:103.13
Low:102.54
Close:103.18
52wk High:107.69
52wk Low:85.36
Shares:42.15M
Float Shares:42.15M
Volume Ratio:0.23
T/O Rate:0.19%
Dividend:1.45
Dividend Rate:1.39%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.13
PE(LYR):-100.81

Loading ...

Circle Pharma: Financing Led by Column Group, Participation from Nextech Invest, Ra Capital Management, Strategic Investment from Eli Lilly and Co

THOMSON REUTERS
·
Sep 16

Human Health Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend

TIPRANKS
·
Sep 16

HeraMED Secures Full-Scale Digital Maternity Rollout with US Health System Lee Health

TIPRANKS
·
Sep 16

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 16

UnitedHealth Group Announces Earnings Release Date

THOMSON REUTERS
·
Sep 16

Health Rounds: New Dye for MRI Exams Detects Lung Cancer Earlier

Reuters
·
Sep 16

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
Sep 16

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
Sep 16

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Reuters
·
Sep 15

LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State

Reuters
·
Sep 15

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Sep 15

LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump

Reuters
·
Sep 15

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Sep 15

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Sep 15

Covista to invest $150,000 in The Health Collaborative

TIPRANKS
·
Sep 15